Edwards Lifesciences Corporation
$90.21
+0.26 (+0.29%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +3.8%
- 3 Months
- +4.3%
- YTD
- +5.8%
- 1 Year
- +11.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 24.5%
- Largest decline max drawdown, since Aug 2025
- -13.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.57
Own EW?
See how EW contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.